Background: Axillary osmidrosis is a distressing problem that can particularly affect a patient’s social life. In severe cases, patients may seek a surgical treatment to achieve a permanent effect. Many treatment techniques involving destruction or removal of the apocrine and eccrine glands have been developed. However, previous treatments have been hindered by surgical or aesthetic concerns. The purpose of this study was to evaluate the effect of the hidden blade scalpel procedure in treating axillary osmidrosis. Methods: From December 2012 to December 2016, 372 patients with axillary osmidrosis underwent the hidden blade scalpel procedure. One 5-mm incision was made at approximately 1 cm beyond the axillary hairline. A hidden blade scalpel was then used to remove the subcutaneous tissue, including the plexus, apocrine and eccrine glands, and hair follicles, from the skin. The clinical efficacy was evaluated using a questionnaire. Results: The hidden blade scalpel procedure resulted in a high percentage of patient satisfaction, a much shorter recovery time, and a low complication rate. Conclusion: The hidden blade scalpel procedure is an effective method for the treatment of axillary osmidrosis.
procedures, including minor trauma to the face. Patients should be made aware that inflammations may occur in other parts of the body when controlling infectious complications in a particular area.Once a foreign body reaction or inflammatory and infectious complication occurs because of filler injection, treatment is difficult, and recurrence is common. The treatment of choice is surgical drainage of the material, removal of the biofilm and capsule, and serial irrigation. It is important to use appropriate intravenous antibiotics concurrently.Although the AQUAfilling filler containing PAAG exhibits an augmentation effect and is effective for rejuvenation, patients should be clearly informed that aesthetic outcomes may change with aging and that fillers can simply be removed by request, but remnant fillers during the process may cause inflammation.Inflammatory complications in filler injection sites may occur at different time points without a definite cause, even in areas other than the injection sites. Therefore, the possibility of inflammation at sites other than that of the injection should always be considered during periodic follow-up, even if the filler injection site shows no complications initially.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.